Minneapolis, MN – Aug 31, 2011 – Regulatory & Clinical Research Institute or “RCRI”, a leading medical device consulting firm announced today it has selected Lisa Griffin Vincent, Ph.D., M.A., as its new Chief Operating Officer and Sr. Principal Advisor. Based on her previous executive and scientific leadership successes, Dr. Vincent will guide RCRI operations during a time when significant economic, regulatory, and industry dynamics hinder advancement of medical device firms and associated service organizations.
As a leading research consulting firm and services provider, RCRI, Inc. is thriving even during difficult economic times. The additional challenges of the FDA on the medical device industry demand that medical service organizations take every action to provide the highest quality service and remain assertive in a significantly competitive industry. As fellow consulting groups and CROs consolidate or become acquired by larger pharmaceutical CROs, RCRI is taking proactive steps to ensure revenue stability and growth. “Bringing Dr. Vincent in to lead our business management and operations is an aggressive move intended to ensure that RCRI remains on top” states Dr. Norsted, “she is a strong addition to our firm and to our clients as she brings a unique combination of both business and scientific research expertise to this critical leadership role. Her goal at RCRI will be to guide corporate growth through these challenging times.”
Dr. Vincent has a bachelor’s of science in Nursing, Master’s in Kinesiology, and PhD in Health Services Research & Policy, all from the University of Minnesota. Dr. Vincent most recently served as Vice President of Global Clinical & Medical Affairs for Medtronic Spine & Biologics and prior to that as the leader for Corporate Clinical across the broader Medtronic enterprise, a Fortune 500 medical device company. Previously, she was VP and COO for the Clinical Research Organization and later Sr. Vice President of Strategic and Business Development at Ingenix Pharmaceutical Services, a subsidiary company of UnitedHealth Group, another Fortune 500 medical firm headquartered in Minnesota.
Many medical device manufacturers must rely on strategic consulting and research services such as those provided by RCRI in order to get their devices through the product development lifecycle, regulatory approval, and reimbursement hurdles to maintain coverage and leadership positions in the marketplace. “Therefore, it is a benefit to our clients that RCRI ensures long term viability and a competitive edge providing strategic and innovative services in a unique partnership with clients, and that is what we plan to do.” stated Dr. Vincent of her new role. “I am thrilled to lead this group of highly experienced consultants and use my technical and business leadership experience to sustain and grow this well known medical device service provider.”
About the Regulatory & Clinical Research Institute, Inc. RCRI was founded in 1999 and has become one of the nation’s largest strategic consulting firms and contract research organizations (CRO) focused on the medical device, in vitro diagnostics, and biologics industries. RCRI is one of the only medical device focused CROs to provide contract research services in regulatory affairs, clinical trial design and management, reimbursement strategies, health economics, quality systems, biostatistics, and data management/information systems.
###
For additional information on RCRI, Inc. and its services please visit: www.rcri-inc.com or email Juli Denny at jdenny@rcri-inc.com or call 952-224-2263.